Chronic Pain: Translating Population-Based Clinical Studies Into Patient-Specific Treatment Strategies (Part 1 of 2)
- Credit Type
- CME
- Credit Amount
- 1
- Release Date
- 11/08/2011
- Expiration Date
- 11/08/2012
- Activity Type
- Webcast
Jointly sponsored by Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, and Asante Communications, LLC.
This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
Intended Audience
This activity is intended for primary care clinicians.
There are no prerequisites for this educational activity.
This activity is the first section of the two-part CME activity Chronic Pain: Translating Population-Based Clinical Studies into Patient-Specific Treatment Strategies, which provides clinicians with information on the underlying pathophysiology of chronic pain and its implications for treatment, and live assessment of a patient with chronic low back pain. The second part can be found here
Learning Objectives
At the conclusion of this program, participants should be better able to:
- Characterize the disease mechanisms underlying the transition from acute to chronic pain and the need for tight clinical management of all patients presenting with pain
- Assess the biopsychosocial needs of patients with chronic pain
- Formulate realistic treatment goals through transparent and ongoing dialogue with patients
- Individualize pharmacotherapy for patients with chronic pain based in part on differential diagnosis, prior medical history, comorbidities, level of function, and treatment goals
- Integrate behavioral therapies tailored to the biopsychosocial and functional needs of patients with chronic pain
Statement of Need / Learner's Gap
Chronic pain impairs multiple dimensions of function—affective, cognitive, physical, and work-related—and, according to population studies, imposes a significant burden on public health.1-3 Substantial progress has been made in deciphering the dysfunctional neural processes that underlie maladaptive chronic states and understanding how the identified pathologic mechanisms can be matched to appropriate therapies.4 Despite distinct challenges, primary care clinicians are uniquely positioned to comprehensively characterize the idiosyncratic combination of biologic, psychologic, and social factors that contribute to the chronic pain experience.2,3 Moreover, because chronic pain profiles change over time, health care providers must be committed to repeated reassessment, adjusting therapeutic regimens as needed to meet the patient’s evolving symptoms and treatment goals. Supported by a growing pool of evidence and expert clinical experience, practitioners, academicians, and medical societies have collaboratively developed screening methodologies and treatment approaches that provide pain relief and improve patient function.5-8 This On-Demand ShowCASE highlights recent scientific insights into chronic pain and their translation into practical assessment strategies and recommended multimodal therapies.
References:
- McCarberg BH, Nicholson BD, Todd KH, Palmer T, Penles L. The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey. Am J Ther. Jul-Aug 2008;15(4):312-320.
- Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. Jul 2007;133(4):581-624.
- Mackintosh C, Elson S. Chronic pain: clinical features, assessment and treatment. Nurs Stand. Oct 8-14 2008;23(5):48-56; quiz 58, 60.
- Woolf CJ. Central sensitization: uncovering the relation between pain and plasticity. Anesthesiology. Apr 2007;106(4):864-867.
- O'Brien EM, Staud RM, Hassinger AD, et al. Patient-Centered Perspective on Treatment Outcomes in Chronic Pain. Pain Med. Sep 1 2009.
- Fishman S. Responsible Opioid Prescribing: A Physician's Guide. Washington, D.C.: Waterford Life Sciences; 2008.
- Lambert M. ICSI releases guideline on chronic pain assessment and management. Am Fam Physician. Aug 15 2010;82(4):434-439.
- Baron R, Tolle TR. Assessment and Diagnosis of Neuropathic Pain. Curr Opin Support Palliat Care. Mar 2008;2(1):1-8.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Albert Einstein College of Medicine and Montefiore Medical Center, and Asante Communications, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Conflict of Interest Statement
The conflict of interest disclosure Policy of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical, product, or device company. Faculty whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to participate.
Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for the use in the United States.
Course Director/Authors and Planning Committee Disclosures
Course director/authors and planning committee members of this program have indicated the following disclosure information:
Jeffrey A. Gudin, MD - Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Speakers Bureau); Pfizer, Inc. (Speakers Bureau); ProStrakan, Inc. (Speakers Bureau).
Steven P. Stanos, DO - Covidien (Consultant); Endo Pharmaceuticals (Consultant, Speakers Bureau); Forest Laboratories, Inc. (Speakers Bureau); King Pharmaceuticals, Inc. (Consultant, Speakers Bureau); Lilly USA, LLC (Consultant, Speakers Bureau); Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Consultant, Speakers Bureau); Pfizer, Inc. (Research, Speakers Bureau); Purdue Pharma L.P. (Consultant).
David M. Kaufman, MD - Has no relevant financial relationships to disclose.
The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine have no disclosures to report other than the following:
Steven Jay Feld, or a member of his household, owns securities in Bioheart, Inc.; Chelsea Therapeutics, Inc.; and Pharmacopeia, Inc.
All additional planning committee members, Asante Communications, LLC, staff, and Albert Einstein College of Medicine staff have no relevant financial relationships to disclose.
Method of Participation
There are no fees for participating in and receiving credit for this activity. The participant will have two opportunities to a score of at least 70% to successfully complete this activity. Credit is available through November 7, 2012.
Disclaimer
The opinions, ideas, recommendations, and perspectives expressed in this program are those of the program presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations, or perspectives of their affiliated institutions, Albert Einstein College of Medicine, Montefiore Medical Center, Asante Communications, LLC, or the activity’s commercial supporters.
Copyright Information
© 2011 Albert Einstein College of Medicine, Montefiore Medical Center, and Asante Communications, LLC. All rights reserved. No part of this program content may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embedded in articles or reviews.
Faculty
